Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
DNMT3A mutation + SF3B1 mutation
i
Other names:
SF3B1, Splicing Factor 3b Subunit 1, Splicing Factor 3b Subunit 1 155kDa, Spliceosome-Associated Protein 155, Splicing Factor 3B Subunit 1, SF3b155, SAP155, Pre-MRNA Splicing Factor SF3b 155 KDa Subunit, Pre-MRNA-Splicing Factor SF3b 155 KDa Subunit, Splicing Factor 3b Subunit 1 155kD, Pre-MRNA Processing 10, SAP 155, Hsh155, PRPF10, PRP10, MDS, DNMT3A, DNA Methyltransferase 3 Alpha, DNA (Cytosine-5-)-Methyltransferase 3 Alpha, DNA (Cytosine-5)-Methyltransferase 3A, DNA MTase HsaIIIA, DNA Cytosi
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1788
;
23451
Related biomarkers:
Expression
Mutation
CNA
Others
‹
DNMT3A mutation (28)
SF3B1 mutation (17)
SF3B1 K666N (5)
DNMT3A mutation + FLT3-ITD mutation (4)
SF3B1 K700E (4)
DNMT3A R882H (3)
FLT3 mutation + DNMT3A mutation (3)
FLT3‐ITD mutation + DNMT3A mutation + NPM1 mutation (3)
DNMT3A mutation + NPM1 mutation (2)
NPM1 mutation + DNMT3A mutation (2)
DNMT3A R882 (1)
DNMT3A mutation + ASXL1 mutation (1)
DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
DNMT3A mutation + IDH mutation (1)
DNMT3A mutation + NRAS mutation (1)
DNMT3A rs11681717 (1)
FLT3-ITD mutation + DNMT3A mutation + ASXL1 mutation (1)
FLT3-ITD mutation + DNMT3A mutation + NRAS mutation (1)
FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
FLT3‐ITD + DNMT3A mutation (1)
KRAS G12D + DNMT3A C559fsX (1)
NPM1 mutation + DNMT3A mutation + KMT2D mutation (1)
NPM1 mutation + SRSF2 mutation + FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
SRSF2 mutation + DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
BCL2 G101V + SF3B1 mutation (1)
SF3B1 K666E (1)
SF3B1 K666Q (1)
TET2 mutation + DNMT3A mutation (0)
DNMT3A mutation (28)
SF3B1 mutation (17)
SF3B1 K666N (5)
DNMT3A mutation + FLT3-ITD mutation (4)
SF3B1 K700E (4)
DNMT3A R882H (3)
FLT3 mutation + DNMT3A mutation (3)
FLT3‐ITD mutation + DNMT3A mutation + NPM1 mutation (3)
DNMT3A mutation + NPM1 mutation (2)
NPM1 mutation + DNMT3A mutation (2)
DNMT3A R882 (1)
DNMT3A mutation + ASXL1 mutation (1)
DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
DNMT3A mutation + IDH mutation (1)
DNMT3A mutation + NRAS mutation (1)
DNMT3A rs11681717 (1)
FLT3-ITD mutation + DNMT3A mutation + ASXL1 mutation (1)
FLT3-ITD mutation + DNMT3A mutation + NRAS mutation (1)
FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
FLT3‐ITD + DNMT3A mutation (1)
KRAS G12D + DNMT3A C559fsX (1)
NPM1 mutation + DNMT3A mutation + KMT2D mutation (1)
NPM1 mutation + SRSF2 mutation + FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
SRSF2 mutation + DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
BCL2 G101V + SF3B1 mutation (1)
SF3B1 K666E (1)
SF3B1 K666Q (1)
TET2 mutation + DNMT3A mutation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
DNMT3A mutation + SF3B1 mutation
Myelodysplastic Syndrome
DNMT3A mutation + SF3B1 mutation
Myelodysplastic Syndrome
lenalidomide
Resistant: B - Late Trials
lenalidomide
Resistant
:
B
lenalidomide
Resistant: B - Late Trials
lenalidomide
Resistant
:
B
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.